Capital World Investors Has $723.42 Million Stock Holdings in The Cooper Companies, Inc. $COO

Capital World Investors boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 25.7% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 10,551,592 shares of the medical device company’s stock after purchasing an additional 2,159,233 shares during the quarter. Capital World Investors owned approximately 0.05% of Cooper Companies worth $723,417,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of COO. Capital International Sarl boosted its position in shares of Cooper Companies by 72.2% in the 3rd quarter. Capital International Sarl now owns 187,857 shares of the medical device company’s stock worth $12,879,000 after purchasing an additional 78,792 shares during the last quarter. Capital International Ltd. CA lifted its stake in Cooper Companies by 61.5% in the third quarter. Capital International Ltd. CA now owns 114,124 shares of the medical device company’s stock valued at $7,824,000 after buying an additional 43,479 shares in the last quarter. Capital International Inc. CA increased its holdings in Cooper Companies by 58.6% during the 3rd quarter. Capital International Inc. CA now owns 96,156 shares of the medical device company’s stock worth $6,592,000 after purchasing an additional 35,539 shares in the last quarter. Capital Group Investment Management PTE. LTD. raised its stake in shares of Cooper Companies by 75.4% in the 3rd quarter. Capital Group Investment Management PTE. LTD. now owns 24,195 shares of the medical device company’s stock valued at $1,659,000 after purchasing an additional 10,399 shares during the period. Finally, Bank of Montreal Can lifted its holdings in shares of Cooper Companies by 48.6% in the third quarter. Bank of Montreal Can now owns 204,479 shares of the medical device company’s stock valued at $14,019,000 after purchasing an additional 66,875 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $74.41 on Wednesday. The stock has a market capitalization of $14.52 billion, a PE ratio of 36.84, a P/E/G ratio of 1.95 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $89.83. The business has a fifty day moving average price of $81.82 and a two-hundred day moving average price of $76.01.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Insiders bought shares and management continues aggressive buybacks, signaling confidence in the company’s long‑term outlook and supporting a rebound thesis; Q1 results beat consensus and buybacks help earnings-per-share support. CooperCompanies Insiders Buy as Rebound Setup Forms
• Positive Sentiment: An analyst raised Cooper’s price target to $103, indicating there is still perceived upside from current levels among some research houses. Cooper Companies (NASDAQ:COO) Price Target Raised to $103.00
• Neutral Sentiment: Analyst coverage pieces (Zacks) profile COO as a long‑term value play and highlight the importance of international revenue trends—useful context but not an immediate catalyst. Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term
• Neutral Sentiment: Another Zacks write-up urges monitoring of international revenue patterns—this is informational for forecasting revisions but not an immediate market mover. Investing in The Cooper Companies (COO)? Don’t Miss Assessing Its International Revenue Trends
• Negative Sentiment: Citigroup cut its price target to $87, signaling at least one major shop has become more cautious on near‑term upside — this likely adds to short‑term selling pressure and contributes to today’s decline. Citigroup Cuts Cooper Companies (NASDAQ:COO) Price Target to $87.00

Insiders Place Their Bets

In related news, Director Lawrence Erik Kurzius purchased 2,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average price of $82.50 per share, for a total transaction of $165,000.00. Following the purchase, the director owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Cynthia L. Lucchese acquired 1,784 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was purchased at an average price of $84.06 per share, with a total value of $149,963.04. Following the purchase, the director owned 9,445 shares in the company, valued at approximately $793,946.70. The trade was a 23.29% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 16,014 shares of company stock worth $1,304,416 in the last quarter. Insiders own 2.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Barclays boosted their target price on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. JPMorgan Chase & Co. lifted their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, December 5th. Finally, William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.